SKN | BioStem Technologies Advances Toward Nasdaq Listing as Regenerative Medicine Strategy Gains Momentum
BioStem Technologies Inc. is advancing its U.S. capital-markets strategy as the regenerative medicine company moves toward a planned Nasdaq listing, following the filing of...
SKN | SunScout Holding Sets Sights on NYSE American IPO as Solar-Powered Robotics Drive Growth Strategy
SunScout Holding Limited is moving toward a U.S. IPO that could bring its solar-powered robotic mower business to the public market, with the offering...
SKN | Rainier Acquisition Files for $75 Million SPAC IPO Targeting Life Sciences Sector
Rainier Acquisition has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $75 million through an initial public offering (IPO),...
SKN | Braveheart Bio Prices Upsized $383 Million IPO Above Range as Investor Demand Lifts Cardiovascular Biotech
Braveheart Bio has priced its upsized initial public offering (IPO) at $18 per share, exceeding its marketed range of $15 to $17 and raising...
SKN | Gravity Acquisition Files for $250 Million SPAC IPO to Pursue Global Acquisition Opportunities
Gravity Acquisition has filed with the U.S. Securities and Exchange Commission to raise up to $250 million through an initial public offering on the...